These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 34000272

  • 1. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
    Manning JJ, Green HM, Glass M, Finlay DB.
    Neuropharmacology; 2021 Aug 01; 193():108611. PubMed ID: 34000272
    [Abstract] [Full Text] [Related]

  • 2. Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor.
    Lu D, Immadi SS, Wu Z, Kendall DA.
    Acta Pharmacol Sin; 2019 Mar 01; 40(3):324-335. PubMed ID: 30333554
    [Abstract] [Full Text] [Related]

  • 3. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.
    J Biol Chem; 2014 Sep 05; 289(36):24845-62. PubMed ID: 25037227
    [Abstract] [Full Text] [Related]

  • 4. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E, Malone DT, Glass M, Sexton PM, Christopoulos A, Leach K.
    Mol Pharmacol; 2015 Aug 05; 88(2):368-79. PubMed ID: 26044547
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Positive allosteric modulation of the cannabinoid CB1 receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics.
    Green HM, Manning JJ, Greig IR, Ross RA, Finlay DB, Glass M.
    Br J Pharmacol; 2024 Oct 05; 181(19):3642-3662. PubMed ID: 38831545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
    Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R.
    Biochem Pharmacol; 2018 Nov 05; 157():148-158. PubMed ID: 30194918
    [Abstract] [Full Text] [Related]

  • 9. Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic hippocampal neurons.
    Mitjavila J, Yin D, Kulkarni PM, Zanato C, Thakur GA, Ross R, Greig I, Mackie K, Straiker A.
    Pharmacol Res; 2018 Mar 05; 129():475-481. PubMed ID: 29158048
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.
    Mallipeddi S, Janero DR, Zvonok N, Makriyannis A.
    Biochem Pharmacol; 2017 Mar 15; 128():1-11. PubMed ID: 27890725
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG.
    Handb Exp Pharmacol; 2015 Mar 15; 231():1-37. PubMed ID: 26408156
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.